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Background: Mucinous tubular and spindle cell carcinoma of kidney (MTSCC-K) is a rare variant of renal tumor.
The current data show most of MTSCCs are of low malignant potential and rare cases metastatic to lymph nodes
have been reported; however, the recorded computed tomography (CT) and follow up data are limited.
Material and method: In the present study, we retrospectively analyzed CT and clinicopathological data of eight
patients with renal MTSCC-K.
Results: A total of eight cases, including six females and two males, were included in this analysis with a mean age
of 48.4 (range 25 to 81) years. Mean tumor size was 4.2 (range 2.5 to 10.0) cm. Preoperative CT demonstrated that
all tumors were slightly enhanced on both corticomedullary and nephrographic phase, which was different from many
other renal cell carcinomas. Three of them were treated with open radical nephrectomy, three with laparoscopic
radical nephrectomy and the other two with laparoscopic partial nephrectomy. No postoperative therapy was applied.
Patients were followed up for 15 to 64 months and there was no evidence of recurrence and metastasis.
Conclusions: The MTSCC-K has special clinicopathological characteristics, low degree of malignancy and relative good
prognosis. The diagnosis mainly depends on the histopathological examination and CT may help to differentiate with
papillary renal cell carcinoma. Surgical treatment is recommended and additional therapies are not necessary.
Virtual slides: The virtual slides for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/
8435581771088249.
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Mucinous tubular and spindle cell carcinoma of the kidney
(MTSCC-K) is a rare pathological entity and has been
described as a specific subtype of renal cell carcinoma
(RCC) in the 2004 World Health Organization classification
[1]. It is characteristically of elongated tubules lined by
cords of spindle cells or cuboidal cells separated by
mucinous extracellular matrix [2-4]. Though it was reported
that MTSCCs showed a relatively good prognosis, the
follow-up data is limited and the clinical behavior of this
tumor remains to be established. And it’s necessary to
gather more clinicopathological features of MTSCC-K for* Correspondence: liudm541@126.com
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stated.better diagnosis and treatment. Thus, we report our
CT and clinicopathological findings of 8 MTSCC-K pa-
tients from January 2006 to December 2010 and relevant
differential diagnoses are discussed.Case presentation
Clinical data
Eight cases of MTSCC-K were identified from a review of
approximately 1430 cases of RCC from the Department
of Urology, Ren Ji Hospital between January 2006 and
December 2010. Detailed clinical information of the 8
patients was listed in the Table 1. One patient was admitted
to the hospital because of intermittent and painless gross
hematuria lasted for 2 weeks, and another patient admitted
for sufferring flank pain for almost half year. There were
no symptoms of hematuria, flank pain or weight loss in the
rest patients. There were no history of fever, hypertension,. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
ain/zero/1.0/) applies to the data made available in this article, unless otherwise
Table 1 Clinicopathological data of the patients with
MTSCC-K




1 M 37 6 T1bN0 64
2 FM 81 7.5 T1bNx NA
3 FM 25 10.5 T2bNx 15
4 FM 59 5.5 T1bN0 34
5 FM 32 5 T1bN0 26
6 FM 60 7.5 T1bNx 60
7 M 34 2.5 T1aN0 64
8 FM 59 3.5 T1aN0 25
M Male, F Female, NA not available.
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examination and routine blood test were within the
normal range.Image findings
Hypovascular renal masses were noted in all cases on
ultrasonography, and subsequent computed tomography
was performed initially to obtain baseline attenuation
values of lesions and to identify calcification; it demon-
strated that all tumors had well-defined margins, and
were slightly enhanced on both corticomedullary phase
(CMP) and nephrographic phase (NP) (Figure 1a,b,c).
The tumors’ attenuation values were ranged from 31 to
40 HU on non-contrast period; and 38 to 50 HU on
CMP, 45 to 67 HU on NP, respectively (Table 2). Plain
chest radiography and Emisson computed tomography
were also preformed to verify there was no distant
metastasis.Treatment methods
Radical nephrectomy was applied to six cases, among
which three were treated via laparoscopic approach.
Laparoscopic partial nephrectomy was applied to another
two cases as the tumors’ sizes were less than 4 cm. No post-
operative therapy was given to any of the eight patients.Figure 1 Contrast enhanced abdominal CT scan. It revealed a tumor on
was slightly enhanced on the corticomedullary phase (b) and nephrographPathological findings
Grossly, these tumors were well-circumscribe solid,
tan-yellow or grayish yellow in appearance (Figure 2A),
with or without foci of hemorrhage or necrosis, the
diameters varied between 2.5 and 10.5 cm. The surroun-
ding perinephric fat, renal pelvis, and hilar vessels were
identified and showed no involvement by tumor. Adrenal
gland and lymph node metastasis were not detected.
Histological examination of these tumors showed they
were consisted of spindle or cuboidal cells arranged in
tubular patterns embeded in mucinous or myxoid stroma
(Figure 2B). However, the proportion of those components
varied. Spindle cell areas were consisted of monotonous
sheets of fairly uniform cells with large eosinophilic
cytoplasm. The tubular pattern was made up of cuboidal
cells with eosinophilic cytoplasm. Immunohistochemically,
the tumors were strongly positive for AMACR (87.5%),
EMA (37.5%), CK7 (62.5%), Vimentin (75%); and weak for
VHL (45%) (Figure 2C, 2D).
Discussion
Mucinous tubular and spindle cell carcinoma is a rare,
malignant renal epithelial tumor which showed a female
predominance and favorable prognosis and had been
recognized as a new entity of RCC, and usually behaved in
a low-grade fashion [1]. More than 80 cases have been
reported and much is known about this tumor [5].
As described before, our results are similar to the
previous studies. They, histologically, are characterized
by small elongated tubules lined by cuboidal, spindle cells
and variable amounts of myxoid stroma.
We further described the clinicopathological findings
about the MTSCCs and pay particular attention to the CT
features. On unenhanced scan, the MTSCC-K, as many of
the other subtypes of solid RCCs, are with attenuation
values ranged from 31 to 40 HU. And the attenuation
values were ranged from 38 to 50 HU on CMP, 45 to 67
HU on NP, respectively. Many previous studies suggest
that MTSCCs may represent a variant of papillary RCC
[2,6], but the CT features are different of them. Post
contrast CT image of papillary RCC in the CMP and NPthe middle portion of the kidney (a), and demonstrated the tumor
ic phase (c).
Table 2 CT Attenuation values (HU) of the patients
with MTSCC-K
Case No. Non-contrast scan CMP NP
1 35 43 63
2 40 50 57
3 NA NA NA
4 31 38 45
5 NA NA NA
6 36 45 54
7 37 50 67
8 NA NA NA
MP Corticomedullar phase, NP Nephrographicphase, NA not available.
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HU [7]. Zhang and his colleagues [8] suggested that low
tumor-to-aorta enhancement ratio or tumor-to-normal
renal parenchyma enhancement ratio was highly indicative
of papillary RCC, which is consistent with the former
findings [9]. However, in our series, the MTSCC-K show
the tumor-to-normal renal parenchyma enhancement ratio
was a little higher than 0.25. MTSCC-K as well as papillary
RCC were typically less vascular compared with most other
subtypes of RCC and most commonly manifested asFigure 2 Histopathological features of MTSCC-K. Gross image of partial
grayish yellow tumor with a psuedocapsule (A); microscopic findings show
and a spindle cell component (B, original magnification × 400 HE); There is
(C, ×200) in both tubules and spindle components and weak for VHL (D, ×homogeneous or peripheral enhancement. Noon [10]
reported MRI characters of an incidentally detected case of
MTSCC-K of an ectopic pregnancy patient; they calculated
the T2 signal intensity ratio of MTSCC-K (0.96) using
the method of Oliva et al. [11], which was different with
papillary (0.67) and clear cell carcinoma (1.41).
In addition, MTSCC-K lack the gains of chromo-
somes 7 and 17 and losses of chromosome Y which are
typical of papillary RCC [12], and using fluorescence in
situ hybridization with centromeric probes for these
chromosomes is helpful in differentiating papillary RCC
from MTSCC-K. Besides, as Behnes et al. [13] reported,
N-cadherin can be used to differentiate subtypes of
papillary RCC and it might be a potential marker for
differentiating MTSCC-K and papillary RCC.
Till now, the origin of MTSCC-K remains uncertain.
In the literature, epithelial markers, especially AMACR,
CK7, EMA and Vimentin, have been reported to be
positive in 80-100% of cases [2], and these may support
the hypothesis of a distal tubule origin. But AMACR
could also be seen in the proximal convoluted tubules
[6,14]. In our series, the tumors were strongly positive for
AMACR (87.5%), CK7 (62.5%), Vimentin (75%); while
only 37.5% showed strong EMA staining and 45% showed
weak for VHL. However, immunohistochemical data donephrectomy specimen displaying a small well-circumscribe solid
s the tumor cells composed of tubules seperated by mucinous stroma
diffuse and strong immunohistochemical expression of Vimentin
200).
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MTSCC-K [2], and more special markers for its diagnosis
need to be established in future.
In our series, prognosis seems to be favorable and
there was no recurrence or metastasis, with a follow-up
of between 15 and 64 months. However, occasional cases
with local recurrence, distant metastasis and regional
lymph node involvement have been reported [4,6,15,16].
In recent, 5 cases of sarcomatoid variant of MTSCCs with
aggressive behavior have been reported in the literature, of
which 3 cases of distant metastases with fatal outcome
were seen [15-17]. It may suggest sarcomatoid changes are
related to the bio-behavior of MTSCCs. And as few cases
in published series have 5 or more years of follow-up,
the true biologic potential and the morphologic criteria
that define it remain unknown [18]. Thus, complete
surgical resection is recommended and careful follow-up
is necessary.
According to the literature and our series, the clinico-
pathological features of MTSCC are indicated as follows.
Firstly, the tumor is characteristically consisted of large
eosinophilic spindle or cuboidal cells arranged in tubular
patterns embeded in mucinous or myxoid stroma [2].
Secondly, CT showed the tumor were slightly enhanced
on both corticomedullary and nephrographic phase and
the tumor-to-normal renal parenchyma enhancement ratio
was a little higher than 0.25, which are different from other
kinds of RCCs, together with MRI [10], it may help for
the differentiation diagnosis of MTSCC. Thirdly, though
the origin and exact histogenenesis of the tumor remain
uncertain, using combination of immunohistochemistry
may be helpful to the diagnosis of MTSCC [19] Last but
not the least, most of MTSCC patients have no manifesta-
tions and prognosis seems to be favorable based on low
histological grade, however, surgical resection and careful
follow-up are recommended.Conclusion
The MTSCC-K has special clinicopathological characteris-
tics, low degree of malignancy and relative good prognosis.
Our reports are benifitial supplement for better under-
standing the clinicopathological features of MTSCC.
Meanwhile, the CT findings, treatment and follow-up data
are valuable information for guiding future clinical practice
but further studies are required to confirm our computed
tomography findings.Consent
Written informed consent was obtained from the patient
for publication of this Case Report and any accompanying
images. A copy of the written consent is available for
review by the Editor-in-Chief of this journal.Abbreviations
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